Jun Ho Ji

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.1K citations

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pharmacology +6

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 662 citations · Full text

Platinum–etoposide Versus Platinum–etoposide, Medicine, Pathology +6

Subchronic Inhalation Toxicity of Silver Nanoparticles

Jae Hyuck Sung, Jun Ho Ji, Jung Duck Park et al. · Toxicological Sciences · 2008 · 499 citations · Full text

Twenty-Eight-Day Inhalation Toxicity Study of Silver Nanoparticles in Sprague-Dawley Rats

Jun Ho Ji, Jae Hee Jung, Sang Soo Kim et al. · Inhalation Toxicology · 2007 · 450 citations

Lung Function Changes in Sprague-Dawley Rats After Prolonged Inhalation Exposure to Silver Nanoparticles

Jae Hyuck Sung, Jun Ho Ji, Jin Uk Yoon et al. · Inhalation Toxicology · 2008 · 379 citations

Nanoparticles, Asthma, Engineering +16